scorecardresearch
Add as a preferred source on Google
Monday, February 16, 2026
TopicCentral Drugs Standard Control Organisation

Topic: Central Drugs Standard Control Organisation

India approves Zolgensma, one of world’s costliest drugs. Why it’s sparked hope, but also concern

Zolgensma is the only drug that promises a cure for Spinal Muscular Atrophy, provided it is administered to affected children before the symptoms appear.

Antibiotics launched in India will soon need CDSCO nod as drug resistance emerges as silent killer

In 2019, bacterial antimicrobial resistance killed between 3 lakh and 10.4 lakh people in India, according to a Lancet report.

Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is sold as heartburn medicine under names Rantac, Aciloc & Zinetac.

On Camera

The debate about spheres of influence reorders India’s position

New world reordering tests New Delhi’s strategic autonomy, balancing ties without succumbing to exclusive dominance zones.

Andhra proposes Rs 100-cr wealth fund, eyes Norway-style sovereign fund model to drive growth

Andhra Pradesh Finance Minister Payyavula Keshav presented a Rs 3.32 lakh crore budget for 2026–27 in the assembly Saturday.

Top US military commander applauds ‘India’s tactical execution’ during Op Sindoor; adds ‘there’s lessons too’

On bilateral ties, Admiral Paparo said India-US ties have an exponential effect on deterrence, because it demonstrates a unity of purpose among us to maintain the peace.

The new Great Game—Trump’s playing for time, China for leverage & India for wiggle room

This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.